1. ACTR-48. FEASIBILITY OF DISCONTINUATION OF ADJUVANT TEMOZOLOMIDE AFTER 12 CYCLES REMAINING WITHOUT PROGRESSION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (5th November 2018) Authors: Nagane, Motoo; Kobayashi, Keiichi; Saito, Kuniaki; Shimizu, Saki; Suematsu, Shinya; Kume, Satoshi; Okamura, Yuma; Shiokawa, Yoshiaki Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗